Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2022

Publisher Name :
Date: 08-Dec-2017
No. of pages: 107
Inquire Before Buying

This report studies the global Musculoskeletal Disorders Therapeutics market, analyzes and researches the Musculoskeletal Disorders Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Pfizer

- AbbVie

- Johnson & Johnson

- Sanofi

- Merck

- Novartis

- Eli Lilly

- AstraZeneca

- Boehringer Ingelheim

- F. Hoffmann-La Roche

- Amgen

- Takeda Pharmaceutical

- Daiichi Sankyo

- LG Life Sciences

- Astellas

- Samsung Bioepis

- Zosano Pharma

- Taisho Pharmaceutical

- 3SBio

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Biologics

- Small Molecules

- Other

Market segment by Application, Musculoskeletal Disorders Therapeutics can be split into

- Osteoarthritis

- Osteoporosis

- Psoriatic Arthritis

- Ankylosing Spondylitis

- Fibromyalgia

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2022

Table of Contents
Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Musculoskeletal Disorders Therapeutics
1.1 Musculoskeletal Disorders Therapeutics Market Overview
1.1.1 Musculoskeletal Disorders Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Musculoskeletal Disorders Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Musculoskeletal Disorders Therapeutics Market by Type
1.3.1 Biologics
1.3.2 Small Molecules
1.3.3 Other
1.4 Musculoskeletal Disorders Therapeutics Market by End Users/Application
1.4.1 Osteoarthritis
1.4.2 Osteoporosis
1.4.3 Psoriatic Arthritis
1.4.4 Ankylosing Spondylitis
1.4.5 Fibromyalgia
1.4.6 Other
2 Global Musculoskeletal Disorders Therapeutics Competition Analysis by Players
2.1 Musculoskeletal Disorders Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 AbbVie
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Johnson & Johnson
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Merck
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Novartis
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eli Lilly
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AstraZeneca
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Boehringer Ingelheim
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 F. Hoffmann-La Roche
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Musculoskeletal Disorders Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Amgen
3.12 Takeda Pharmaceutical
3.13 Daiichi Sankyo
3.14 LG Life Sciences
3.15 Astellas
3.16 Samsung Bioepis
3.17 Zosano Pharma
3.18 Taisho Pharmaceutical
3.19 3SBio
4 Global Musculoskeletal Disorders Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Type (2012-2017)
4.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Musculoskeletal Disorders Therapeutics in Future
4.4 Top Consumer/End Users of Musculoskeletal Disorders Therapeutics
5 United States Musculoskeletal Disorders Therapeutics Development Status and Outlook
5.1 United States Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
5.2 United States Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU Musculoskeletal Disorders Therapeutics Development Status and Outlook
6.1 EU Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
6.2 EU Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 Japan Musculoskeletal Disorders Therapeutics Development Status and Outlook
7.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
7.2 Japan Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 China Musculoskeletal Disorders Therapeutics Development Status and Outlook
8.1 China Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
8.2 China Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 India Musculoskeletal Disorders Therapeutics Development Status and Outlook
9.1 India Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
9.2 India Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Musculoskeletal Disorders Therapeutics Development Status and Outlook
10.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Musculoskeletal Disorders Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Musculoskeletal Disorders Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Musculoskeletal Disorders Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)
12 Musculoskeletal Disorders Therapeutics Market Dynamics
12.1 Musculoskeletal Disorders Therapeutics Market Opportunities
12.2 Musculoskeletal Disorders Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Musculoskeletal Disorders Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Musculoskeletal Disorders Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Musculoskeletal Disorders Therapeutics Product Scope
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) (2012-2017)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Regions in 2016
Figure United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Type in 2016
Figure Biologics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Small Molecules Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Osteoarthritis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Osteoarthritis (2012-2017)
Table Key Downstream Customer in Osteoporosis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Osteoporosis (2012-2017)
Table Key Downstream Customer in Psoriatic Arthritis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Psoriatic Arthritis (2012-2017)
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Ankylosing Spondylitis (2012-2017)
Table Key Downstream Customer in Fibromyalgia
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Fibromyalgia (2012-2017)
Table Key Downstream Customer in Other
Figure Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Takeda Pharmaceutical Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical (2012-2017)
Figure Takeda Pharmaceutical Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table LG Life Sciences Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of LG Life Sciences (2012-2017)
Figure LG Life Sciences Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Astellas Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Astellas (2012-2017)
Figure Astellas Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Samsung Bioepis Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Samsung Bioepis (2012-2017)
Figure Samsung Bioepis Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Zosano Pharma Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Zosano Pharma (2012-2017)
Figure Zosano Pharma Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Taisho Pharmaceutical Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of Taisho Pharmaceutical (2012-2017)
Figure Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table 3SBio Basic Information List
Table Musculoskeletal Disorders Therapeutics Business Revenue (Million USD) of 3SBio (2012-2017)
Figure 3SBio Musculoskeletal Disorders Therapeutics Business Revenue Market Share in 2016
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2012
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2013
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2014
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2015
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2016
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2017
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Musculoskeletal Disorders Therapeutics
Figure United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure United States Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure EU Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Japan Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure China Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure China Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure India Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure India Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size Share by Players in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions in 2022
Figure United States Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Type in 2022
Table Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Musculoskeletal Disorders Therapeutics Market Size (Million USD) by Application in 2022
  • Sarcopenia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 71
    Sarcopenia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Pipeline Review, H2 2018, provides an overview of the Sarcopenia (Musculoskeletal Disorders) pipeline landscape. Sarcopenia is an aging-associated condition which is characterized by loss of muscle mass, strength and function. Symptoms include weakness, loss of endurance and poor balance. Causes of sarcopenia include......
  • Degenerative Disc Disease - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 72
    Degenerative Disc Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Pipeline Review, H2 2018, provides an overview of the Degenerative Disc Disease (Musculoskeletal Disorders) pipeline landscape. Degenerative disc disease is refers to degeneration of intervertebral discs of the spinal column. The main symptom of degenerative disc disease is pain, which o......
  • Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 319
    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018, provides an overview of the Systemic Sclerosis (Scleroderma) (Immunology) pipeline landscape. Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pains, joint......
  • Myasthenia Gravis - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 133
    Myasthenia Gravis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Pipeline Review, H2 2018, provides an overview of the Myasthenia Gravis (Immunology) pipeline landscape. Myasthenia gravis is autoimmune neuromuscular disease characterized by weakness and rapid fatigue of any of the muscles under voluntary control. Symptoms include drooping of one or both eyelids, dipl......
  • Birch Pollen Allergy - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 45
    Birch Pollen Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape. Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingli......
  • House Dust Mite Allergy - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 51
    House Dust Mite Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H2 2018, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape. House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. As......
  • Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment, Number of Patients Treated, Specifications & Company Analysis - Global Forecast to 2024
    Published: 12-Jul-2018        Price: US 2390 Onwards        Pages: 429
    The rise in popularity of proton therapy is continuing across the globe. It is estimated that more than 165,000 patients suffering from a variety of cancers, such as prostate cancer, brain tumors, etc. have already been successfully treated using this method. In fact, the proton therapy market is on track to become a multibillion-dollar industry by 2024. The number of proton therapy centers is increasing globally. Still, industry experts believe that players will miss out on a majority of can......
  • Global and United States Infantile Spasms Therapeutics Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 111
    Summary An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending for......
  • 2013-2023 Global Infrared light therapy device Industry Report
    Published: 02-Jul-2018        Price: US 4000 Onwards        Pages: 150
    The global market size of Infrared Light Therapy Device is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This repor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs